Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer death worldwide. Despite recent advances in the diagnosis and treatment of …

Chemokines are small molecular weight proteins primarily known to drive migration of
immune cell populations. In both acute and chronic liver injury, hepatic chemokine …

Chronic infection with hepatitis C virus (HCV) can induce insulin resistance (IR) in a
genotype‐dependent fashion, thus contributing to steatosis, progression of fibrosis and …

Taxol (paclitaxel) is a new antineoplastic drug that has shown promise in the treatment of
different tumor types. However, the molecular mechanisms governing taxol-induced …

Hepatitis C virus (HCV) is an RNA virus that is unable to integrate into the host genome.
However, its proteins interact with various host proteins and induce host responses. The …

Chronic hepatitis C virus (HCV) infection is associated with the production of serum
cytokines, including transforming growth factor (TGF)‐β2. Despite the occurrence of hepatic …

NF-κB (nuclear factor κB) is a heterodimeric transcription factor that is constitutively
expressed in all cell types and has a central role as a transcriptional regulator in response to …

Diabetes mellitus is a common and growing global health problem leading to several
complications. Among these periodontal diseases are considered as the sixth complication …

Type 2 diabetes (T2D) and HCV infection are common conditions involving, respectively, at
least 170 and 130 million people worldwide. However, the distribution of such cases does …

Hepatitis C virus (HCV) infection results in liver injury and long‐term complications, such as
liver cirrhosis and hepatocellular carcinoma. Liver injury in HCV infection is believed to be …